The clinical research program will be led by Jeffrey Stout, MusclePharm’s scientific advisor, who will study the effects of MusclePharm’s products on high-intensity interval training, on aerobic and anaerobic power, repeated sprint ability, body composition and training volume, along with other faculty in the department.
MusclePharm CEO Brad Pyatt said that they are excited to be working with the University of Oklahoma and such an esteemed team focused on health and exercise science to further understand the results of MusclePharm products.
"As one of the developers of nutritional supplements, we continue to focus on safe and scientific product formulations that will benefit the global healthy living and wellness industry as we strive to increase sales and profitability long-term," Pyatt said.